Seite - 81 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Bild der Seite - 81 -
Text der Seite - 81 -
Conniotet al. Nanocarriers for immunecell targetingand tracking
FIGURE5 |Thestealtheffect fromNPfunctionalizationwithPEG. (A)
Particulate foreignentities inbodyfluidsarepromptly coveredwith
opsonins, suchas the immunoglobulins IgGand IgAand thecomplement
proteinsC3bC4b, inaprocesscalledopsonization.Opsoninsmark the
particulateentity tophagocytosis through their recognitionbyFc receptors
onphagocytic cells, suchasmacrophages. (B)FunctionalizationofNPs
withPEGbygrafting, conjugationoradsorption—note the
“mushroom-like” (a) or“brush-like” (b) configurationofPEG
chains—providessteric stabilizationandstealthproperties, preventing the
adsorptionofopsoninsat thesurfaceofnanoparticles.PEGhydrophilicity
attractswatermolecules toparticlesurfaceavoiding theadsorptionof
opsoninsatNPsurface, rendering them“invisible” tophagocytic cells.
priortonanocarrierproductionmaybeadvantageous,sothatthe
conjugation yield of the ligand to the polymer can be assessed
and controlled.Nanocarriers can be thus producedwith awell-
characterized (co)polymer and the density of ligands on their
surface can be tailored. Physicochemical properties of the poly-
mers must be evaluated after ligand conjugation, because the
hydrophilic/hydrophobic balancemay be altered, particularly if
macromolecules are linked(Betancourt et al., 2009; Sperlingand
Parak,2010;Nicolasetal., 2013).
The strategy of attaching ligandmolecules after nanocarrier
production is usually applied, when antibodies, proteins and
polypeptidesarechosenas targetingagents.As someorganic sol-
vents are generally used in the preparation of nanosystems, this
methodispreferredtoavoiddenaturationofthesecondarystruc-
tureof the ligands.Also, since theyarebulkymolecules, theywill
disturb the hydrophilic/hydrophobic balancewhich candifficult
themethodofnanocarrierproduction(Nicolas et al., 2013).The
drawbacks of this approach are related with subsequent purifi-
cationof the formulationand its characterization.Theprocesses
frequentlyused forpurification, suchas centrifugation,filtration
anddialysis,maydegradeoralter thenanosystems.Additionally,
it is usually difficult to prove that the ligand is covalently linked
to the surfaceof thenanocarrier andnotonly adsorbed (Nicolas
etal., 2013).
Ligation strategies for functionalization. Several pathways have
been developed to attach ligands onto nanosystems surface,
suchas thecarbodiimide strategy, theMichael additionpathway,
the biotin–streptavidin approach and theCopper-catalized liga-
tionmethod (Betancourt et al., 2009; Nicolas et al., 2013). The
native terminal groups of some polymers or specific moieties, introducedthroughchemicalmodifications,aregenerallyusedto
applytheseschemesof functionalization.For instance,carboxylic
acid terminals in aliphatic polyesters and poly(ethylene glycol)
(Betancourtetal., 2009).
Themost used scheme is based on the carbodiimide chem-
istry. It relies on the coupling of a molecule containing a ter-
minal aminegroupwithanotherwith anN-hydroxysuccinimide
(NHS) ester end or an end group that can be easily esterified
to NHSmoiety (Betancourt et al., 2009; Nicolas et al., 2013).
TheMichael addition pathway is based on the thiol-maleimide
coupling. Maleimide-polymers are used to produce nanocarri-
ers, which are then decorated with thiol-containing targeting
agents (Betancourt et al., 2009; Nicolas et al., 2013). However,
the presence of native thiol groups in somemolecules, as pro-
teins and peptides, is usually low (or absent in some cases) and
many are hard to access. To overcome this, disulfide bonds can
be reduced in thiol groups or heterobifunctional cross-linking
agentsmaybeused(Nicolasetal.,2013).Thebiotin–streptavidin
approach utilizes a strong non-covalent biological interaction
betweenbiotinandavidin (Betancourt et al., 2009;Nicolas et al.,
2013). Still, for this strategy, a targeting agent is usually chem-
ically bound to avidin, which is a bulky glycoprotein that may
thenobstruct the interaction ligand-receptor, essential for target-
ing (Betancourt et al., 2009). TheCopper-catalized ligation is a
highly efficientmethod, based on a cycloaddition reaction that
fits in the“clickchemistry”classof reactions.Thechemical reac-
tion is developed in mild conditions and with little or absent
byproducts.Themajordisadvantageof thisapproach is theelim-
ination of the Cu-based catalyst used for the reaction (Nicolas
etal., 2013).
Functionalization of nanosystems for immune cell targeting.
Extensiveresearchhasbeenmaderegardingcell surfacereceptors
in immune cells, the so-called PRRs. PRRs recognize pathogen-
associated molecular patterns (PAMPS) and are involved in
several stages of the immune response, from its initiation and
proliferation, to its execution (Kumar et al., 2009). Different
types of molecules may act as PAMPs, known as “danger sig-
nals,” for instance lipids, lipoproteins, proteins, carbohydrates
and nucleic acids. The recognition of PAMPs by PRRs triggers
immune responses by activating multifactorial signaling path-
ways. This leads to the induction of inflammatory responses
mediated by several cytokines and chemokines (Kumar et al.,
2009).
Several classes of PRRs have been reviewed, such as TLRs,
retinoic-acid inducible gene (RIG)-like receptors (RLRs),
nucleotide oligomerization domain (NOD)-like receptors
(NLRs), DNA receptors (cytosolic sensors for DNA), scavenger
receptors, and C-type lectin receptors (CLRs) (Kumar et al.,
2009; Carrillo-Conde et al., 2011; Shen et al., 2013; Silva et al.,
2013). Inmammals, themost studiedPRRclass is theTLRsclass.
TLRsarepredominantlyexpressedbyAPCs,asDCs,but theyare
also found on cells of the adaptive immune system, such as in
αβT cells, regulatory T cells, and γδT cells, as well asNKT cells
(Wesch et al., 2011). Through TLR activation, both the innate
and the adaptive immune responses can be engaged, either by
directactivationofTLRswiththeir ligandsonTandBcells,orby
Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 81
Cancer Nanotheranostics
What Have We Learnd So Far?
- Titel
- Cancer Nanotheranostics
- Untertitel
- What Have We Learnd So Far?
- Autoren
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Herausgeber
- Frontiers in Chemistry
- Datum
- 2016
- Sprache
- englisch
- Lizenz
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Abmessungen
- 21.0 x 27.7 cm
- Seiten
- 132
- Schlagwörter
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Kategorien
- Naturwissenschaften Chemie